Jul 04, 2019–RhoVac’s reports positive results from the 12 months follow-up of the company’s phase I/II clinical study (regulatory)Jun 05, 2019–RhoVac AB receives approval to start clinical phase IIb study in Denmark (regulatory)May 21, 2019–RhoVac publishes research results prior ASCO's meeting (regulatory)
